COLUMNS by Moira Dower

COLUMNS

BY MOIRA

Moira Dower is a freelance writer/editor on healthcare and pharmaceutical issues.

She was formerly Editor of Scrip World Pharmaceutical News and Managing Editor of Scrip Magazine.

New challenge for industry – governments want bigger role in price setting and R&D

The “financial toxicity” posed by very expensive cancer therapies was a major talking point at the recent American Society of Clinical Oncology (ASCO) meeting. And in May the World Health Organisation’s major forum on fair pricing of medicines concluded that governments must play a stronger role in setting prices and R&D priorities. The forum called for much greater transparency on drug pricing, along with a move away from value-based pricing and removal of the link between prices and R&D costs. As the debate intensifies, I make no apologies for returning to the subject of drug pricing. Pricing of medicines has always been predominantly a national concern. Companies negotiate prices at natio

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Basic Square

in consolidated operations with

alion.png
PVW, Amsterdam, reclamebureau, advertising, agency, gezondheidszorg, healthcare, medisch, medical, prins, waard
PVW, Amsterdam, reclamebureau, advertising, agency, gezondheidszorg, healthcare, medisch, medical, prins, waard
n=5.png
milk.png

©2020 PVW AMSTERDAM